Combination therapy with donepezil and sertraline in the treatment of Alzheimer's disease

Alzheimer's Reports

Volumn 1, Issue 5, 1998, Pages 303-308

  Shua Haim, Joshua R ^a   Shua Haim, Vered ^a   Ross, Joel S ^a  

^a JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747734160     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aguglia E, Cassacchia M, Cassano GB et al. (1993). Double-blind study of the efficacy and safety of sertraline versus fluooxetine in major depression. Int Clin Psychopharm 8, 197-202.
2. American Psychiatric Association, Committee on Nomenclature and Statistics (1987): Diagnosis and statistical manual of mental disorders, Edn 3. American Psych Ass, Washington DC: p 121.
3. Davis KL, Thal LJ, Gamzu ER et al.(1992). A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 327, 1253-1259.
4. Doraiswamy M (1996). Current cholinergic therapy for symptoms of Alzheimer's disease. J Prim Psychiatr 1-11.
5. Farlow M, Gracon SI, Hershey LA et al. (1992). A controlled trial of tacrine in Alzheimer's disease. JAMA 268, 2523-2529.
6. Greist J, Chouinard G, DuBoff E et al. (1995). Double-blind parallel comparison of three dosages of Sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatr 52, 289-295.
7. Haider A, Miller RD and Staton D (1993). Use of serotonergic drugs for treating depression in older patients. Geriatrics 48, 48-51.
8. Katz S (1983). Assessing self maintenance; activity of daily living, mobility and instrumental activity of daily living. J Am Geriatr Soc 31, 721-727.
9. Maning FC (1994). Tacrine therapy for the dementia of Alzheimer's disease. Am Fam Phys 50, 819-823.
10. McKhann G, Drachman D, Folstein M et al. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
11. Reuben DB, Yoshiawa TT and Besdine RW (1996). Geriatric Syndromes. Part III Dementia. Kendell Hunt Publishing: pp 105-114.
12. Rogers SL, Doody R, Mohs R and Friedhoff LT (1996a). E2020 produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer's disease: results of a 30-week phase III trial (abstract). Neurology 46, 217.
13. Rogers SL, Friedhoff LT, Apter JT et al. (1996b). The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293-303.
14. Schneider LS and Olin JT (1994). Overview of clinical trials of Hydergine in dementia. Arch Neurol 51, 787-798.
15. Schneider LS and Tariot PN (1994). Emerging drugs for Alzheimer's disease. Clin Geriat Med 10, 921.
16. Shikh JI and Yesavage JA (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol 5, 170.
17. Shua-Haim JR, Burnstein LA and Ross JS (1995) C-ADAT: Caregivers Alzheimer's disease assessment tool. Am J Alz Dis Rel Disord 10, 2-10.
18. Shua-Haim JR, Shua-Haim VK and Ross JS (1997a). Donepezil (Aricept): The caregivers voice and clinical impression. Am J Alz Dis Rel Disord 12, 272-279.
19. Shua-Haim JR, Sabo MR, Comsti E and Ross JS (1997b). Depression in the elderly. Hosp Med July 44-58.
20. Sindrup SH (1996). The use of antidepressant drugs in the treatment of painful diabetic neuropathy. Clin Geriatric 4, 19-42.
21. Watkins PB, Zimmerman HJ, Knapp MJ et al. (1994). Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 271, 992-998.